ANGPTL8 and liver dysplastic nodule: Moreover, to test the efficacies of serum sestrin 2 levels and betatrophin levels in differentiating patient with diabetic nephropathies from diabetic-only individuals, to propose or reject a possible therapeutic use of sestrin 2 or betatrophinin the prevention of DN.